Opportunity for Indian pharma industry to capitalise on escalating US-China trade war: GlobalData
Both China and the US are key markets for India from the pharma industry perspective
It’s been more than a year since China and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
A silver lining to withdrawal of GSP benefits?
Will US President Trump’s mission to Make America Great Again turn out to be a great fillip for PM Modi’s Make in India campaign?…
25 batches of drugs of 18 pharma companies found substandard since January 2018 by BPPI
While 17 out of the 18 companies are private, one is a public sector unit (PSU) - Indian Drugs and Pharmaceuticals Limited (IDPL)
Digital era of drug development
The Indian pharma sector needs more actionable and optimised drug development and delivery models driven by data and new-age…
Express Pharma June 16-30, 2019
India's Foremost Pharma & Biotech Magazine ~ Digital Era of Drug Development
Biocon’s biologics facilities in Bengaluru received GMP compliance certificate from EMA
The certification will enable the company to continue addressing the growing needs of patients in the EU markets
Univercells granted $14.3 mn to deliver affordable measles and rubella vaccines
The grant has been given by the Bill and Melinda Gates Foundation to increase the availability of measles and rubella (M&R)…
Sun Pharma announces Late-Breaking Phase 2 data showing potential of ILUMYA (tildrakizumab-asmn)
The drug has been designed to improve joint and skin symptoms of Psoriatic Arthritis. Over 71 per cent of patients treated with…
DRL to sell neurology branded products to Upsher-Smith Laboratories
Dr Reddy’s would sell its US and select territory rights for ZEMBRACE SYMTOUCH and TOSYMRATM, which are commercialized through its…
‘The Future of Supply Chain Management’ by OPPI
The Organisation of Pharmaceutical Producers of India (OPPI), in collaboration with Indian Pharmaceutical Alliance and Indian Drug…